Clin2
NCT07169747Possibly a fitRecruiting

Psilocybin with therapy for young adults with anorexia

Anorexia Nervosa

Treatments studied

Part of Mental health clinical trials.

This study tests two different doses of psilocybin, a substance that may help change thinking patterns, given alongside psychological support to young adults with anorexia nervosa. It aims to see if it is safe and helpful for weight recovery and mental health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
16 years to 35 years
Study type
Interventional

Who can take part

  • You are between 16 and 35 years old
  • You have anorexia nervosa, even if currently in partial recovery
  • You have had a period of weight restoration to a BMI of at least 17, followed by a later weight loss
  • Your current BMI is above 16
  • You are in stable contact with a psychiatric care unit
  • You have not used psychedelics in the past and have no serious heart, seizure, or mental health conditions like psychosis or bipolar disorder

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06399263Recruiting· Phase 2
Psilocybin for anorexia in young adults

This trial tests whether a single dose of psilocybin (a psychedelic substance) can help treat anorexia nervosa in young adults. It involves taking the medication in a safe, supervised setting and participating in therapy sessions with a support person.

San Francisco, California
NCT07079852Not yet recruiting· Phase 1/Phase 2
Psilocybin and its effects on memory and brain function

This trial tests how psilocybin, a psychedelic substance, affects your thinking, memory, and brain activity. Researchers want to understand these effects in healthy adults who have used psychedelics before.

Austin, Texas
NCT07183748Recruiting· Phase 2
Psilocybin microdosing plus therapy for hard-to-treat depression

This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.

Beersheba
NCT07582120Not yet recruiting· Phase 2
Psilocybin-Assisted Therapy for Depression

This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.

St Louis, Missouri
NCT06233344Recruiting· Phase 2
Mindfulness and psilocybin study for healthy adults

This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.

Los Angeles, California
NCT06442423Recruiting· Phase 1
Psilocybin study for people with psychiatric symptoms

This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.

New Haven, Connecticut

Hear when a new Anorexia Nervosa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.